tiprankstipranks
Molecular Partners (MOLN)
NASDAQ:MOLN

Molecular Partners (MOLN) Similar Stocks

Compare
27 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Molecular Partners
$4.68
$197.40M
6.39%
0 Buy
0 Hold
0 Sell
Moderate Buy
Alnylam Pharma
$250.59
$32.49B
61.94%
15 Buy
3 Hold
0 Sell
Strong Buy
Regeneron
$700.33
$76.09B
18.29
-28.53%
16 Buy
3 Hold
1 Sell
Strong Buy
Vertex Pharmaceuticals
$484.24
$123.34B
13.46%
14 Buy
12 Hold
1 Sell
Moderate Buy
Sarepta Therapeutics
$106.28
$10.36B
88.29
-19.66%
13 Buy
1 Hold
1 Sell
Strong Buy
Argenx Se
$644.48
$39.15B
57.37%
11 Buy
1 Hold
1 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
MOLN
Molecular Partners
4.68
0.67
16.71%
ALNY
Alnylam Pharma
250.59
92.94
58.95%
REGN
Regeneron
700.33
-279.61
-28.53%
VRTX
Vertex Pharmaceuticals
484.24
54.13
12.59%
SRPT
Sarepta Therapeutics
106.28
-30.25
-22.16%
ARGX
Argenx Se
644.48
234.96
57.37%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis